suliqua
sanofi winthrop industrie - insulin glargine, lixisenatide - diabetes mellitus, type 2 - narkotika anvendt i diabetes - suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sglt-2 inhibitors.
amaryl 1 mg tabletter
sanofi a/s - glimepirid - tabletter - 1 mg
amaryl 2 mg tabletter
sanofi a/s - glimepirid - tabletter - 2 mg
amaryl 3 mg tabletter
sanofi a/s - glimepirid - tabletter - 3 mg
amaryl 4 mg tabletter
sanofi a/s - glimepirid - tabletter - 4 mg
diclofenac "bluefish" 25 mg enterotabletter
bluefish pharmaceuticals ab - diclofenacnatrium - enterotabletter - 25 mg
diclofenac "bluefish" 50 mg enterotabletter
bluefish pharmaceuticals ab - diclofenacnatrium - enterotabletter - 50 mg
dicuno 25 mg filmovertrukne tabletter
vitabalans oy - diclofenackalium - filmovertrukne tabletter - 25 mg
dicuno 50 mg filmovertrukne tabletter
vitabalans oy - diclofenacnatrium - filmovertrukne tabletter - 50 mg
glimepirid "actavis" 1 mg tabletter
actavis group ptc ehf. - glimepirid - tabletter - 1 mg